Fluorescence-Coupled Ubiquitination Assay as a High-Throughput Screening Strategy for Novel Cereblon Degraders

Yanan Deng, Shiling Yang, Hesong Xu, Xiyao Ding, Ying Xu, Zhengzheng Ye, Yan Chen, Zemin Zhang, Jin Lin, Huan Xiong, Zizhong Zhang, Kun Yang, Yiran Hu, Ke Xu, Cheng Luo, Shijie Chen, Hua Lin, Zhihai Li

Research output: Contribution to journalArticlepeer-review

Abstract

Cereblon (CRBN)-based protein degradation, via molecular glue degraders (MGDs) and proteolysis-targeting chimeras (PROTACs), is a promising cancer treatment strategy in targeted protein degradation (TPD). However, novel degraders discovery remains limited due to the lack of robust, high-throughput screening (HTS) methods for processing pools of purified compounds or complex chemical synthesis mixtures. Here, we introduce an innovative HTS strategy that employs a highly sensitive, fluorescence-coupled ubiquitination assay to identify CRBN-based degraders. This approach tracks ubiquitinated target proteins via gel-based analyses, and thereby progressively narrows down the list of potential degrader molecules from large-scale compound libraries or chemical reaction mixtures. Using this strategy, we identified LL-BPTF-8, a promising lead compound of PROTAC degrader with high potency and selectivity that targets the bromodomain PHD finger transcription factor (BPTF). Overall, our method offers a low-cost, rapid, and versatile platform for the HTS of protein degrader candidates, significantly streamlining the discovery of novel degraders.

Original languageEnglish
Pages (from-to)10111-10127
Number of pages17
JournalJournal of Medicinal Chemistry
Volume68
Issue number10
DOIs
StatePublished - 22 May 2025

Fingerprint

Dive into the research topics of 'Fluorescence-Coupled Ubiquitination Assay as a High-Throughput Screening Strategy for Novel Cereblon Degraders'. Together they form a unique fingerprint.

Cite this